Company intelligence / Profile preview

iXLife Capital

Paris (Metropolitan region / near Paris), France

Ownership: Private
Development stage: Other

Overview

iXLife Capital is an active venture capital investor focused on early-stage biotechnology and life science companies, supporting the development of new therapies and devices, particularly for cancer and neurological diseases[1][2][3][8].

Industry: Investors

Beyond the preview

Go deeper on iXLife Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iXLife Capital.

Explore the full profile